Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,326 | -116,738 | N/A | 362,500 | 385,200 |
| Depreciation Amortization | 2,583 | 650 | N/A | 121,000 | 110,500 |
| Income taxes - deferred | N/A | N/A | N/A | 47,200 | 69,000 |
| Accounts receivable | N/A | N/A | N/A | 11,600 | -33,600 |
| Accounts payable and accrued liabilities | 4,092 | 2,436 | N/A | -15,400 | 33,600 |
| Other Working Capital | -3,401 | 26,149 | N/A | -210,400 | -222,400 |
| Other Operating Activity | 3,049 | 67,205 | 0 | 107,300 | 35,900 |
| Operating Cash Flow | $-72,003 | $-20,298 | $N/A | $423,800 | $378,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,518 | -13,124 | N/A | -40,800 | -125,000 |
| Net Acquisitions | N/A | N/A | N/A | -3,000 | -685,100 |
| Purchase Of Investment | -130,210 | -300 | N/A | N/A | N/A |
| Sale Of Investment | 76,069 | N/A | N/A | 1,500 | 2,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 6,000 |
| Investing Cash Flow | $-66,659 | $-13,424 | $N/A | $-42,300 | $-802,100 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 4,100 | -27,600 |
| Debt Issued | N/A | N/A | N/A | 496,000 | 605,800 |
| Debt Repayment | N/A | N/A | N/A | -1,012,700 | -10,300 |
| Common Stock Issued | 185 | 10 | N/A | 176,900 | 112,700 |
| Dividend Paid | N/A | N/A | N/A | -145,700 | -130,100 |
| Other Financing Activity | 41,094 | 179,717 | 0 | 12,600 | 13,700 |
| Financing Cash Flow | $41,279 | $179,727 | $N/A | $-468,800 | $564,200 |
| Exchange Rate Effect | N/A | N/A | N/A | -1,200 | 7,100 |
| Beginning Cash Position | 147,936 | 1,931 | N/A | 365,700 | 218,300 |
| End Cash Position | 50,553 | 147,936 | N/A | 277,200 | 365,700 |
| Net Cash Flow | $-97,383 | $146,005 | $N/A | $-88,500 | $147,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,003 | -20,298 | N/A | 423,800 | 378,200 |
| Capital Expenditure | -12,518 | -13,124 | N/A | -128,500 | -136,500 |
| Free Cash Flow | -84,521 | -33,422 | 0 | 295,300 | 241,700 |